Study for the Treatment of Ocular Chronic Graft-Versus-Host Disease (GVHD) With Amniotic Fluid Eye Drops (AFED)

  • End date
    Nov 11, 2024
  • participants needed
  • sponsor
    University of Utah
Updated on 11 February 2021


A Randomized, Double-blinded, Placebo-Controlled Study for the Treatment of Ocular Chronic Graft Verses Host Disease with Processed Amniotic Fluid (pAF) Drops.


This is a randomized (to each eye, within patient), double-blinded, placebo-controlled study of the efficacy of Processed Amniotic Fluid (pAF) in patients with hematologic malignancies who have undergone Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) and are diagnosed with Chronic Graft Verses Host Disease of the eye.

Condition Ocular Graft Versus Host Disease
Treatment Saline solution, Amniotic Fluid Eye Drops (AFED)
Clinical Study IdentifierNCT03298815
SponsorUniversity of Utah
Last Modified on11 February 2021


Yes No Not Sure

Inclusion Criteria

Patients diagnosed within 3 years after hematopoietic stem cell transplant for any disease, with any graft and any conditioning regimen with at least one of the
Dry eye symptoms partially affecting (requiring lubricant drops > 3 x per day or punctal plugs) or significantly affecting (special eyeware to relieve pain) activities of daily living (ADL)
Unable to work because of ocular symptoms
Loss of vision due to keratoconjunctivitis sicca (KCS)
Patients may be using bilateral scleral lenses and/or bilateral punctal plugs at the time of accrual
Patients who are 18 years of age or older
Willing and able to provide informed consent

Exclusion Criteria

Patients who have any other reversible cause for dry eye at the time of accrual
More than 2 lines of therapy beyond corticosteroids with or without calcineurin inhibitors or sirolimus
Relapsed malignancy after transplantation
A difference in dryness between both eyes of more than 2 points of the grading provided by the International Dry Eye Workshop (DEWS) 2007 report
Patients who are pregnant or plan to become pregnant while participating in the study
Patients who are not willing to discontinue the use of any eye drops, with the exception of non-medicated lubricant eye drops (artificial tears). All eye drops (excluding non-medicated lubricant eye drops) must be stopped at least seven days before treatment with pAF
Inability to comply with the investigational plan and visit schedule for any
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact



Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note